Loading…
Loading…
TMO · NYSE · Healthcare
“At 26 times earnings, TMO demands exceptional growth sustainability to justify its premium valuation against the margin of safety principle.”
— In the voice of Graham
Project future earnings using analyst estimates and historical growth rates. Model 5-year earnings trajectories.
Market Cap
$174.59B
P/E Ratio
26.04
Forward P/E
—
EPS
$17.77
PEG Ratio
2.90
Book Value
$141.66
Dividend Yield
0.36%
Profit Margin
15.05%
ROE
12.55%
Use the interactive growth projection with pre-loaded data for Thermo Fisher Scientific Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for TMO: